Cargando…
Neoadjuvant chemotherapy for primary adenocarcinomas of the urinary bladder: a single-site experience
BACKGROUND: Adenocarcinoma of the urinary bladder is a rare malignancy. Radical surgery is suggested as the best available treatment for early-stage disease, but there is currently no consensus on standard chemotherapy regimen for advanced stage. We assessed the feasibility and effect of neoadjuvant...
Autores principales: | Yu, Bin, Zhou, Jin, Cai, Hongzhou, Xu, Ting, Xu, Zicheng, Zou, Qing, Gu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328949/ https://www.ncbi.nlm.nih.gov/pubmed/25631709 http://dx.doi.org/10.1186/1471-2490-15-3 |
Ejemplares similares
-
Comprehensive FGFR3 alteration-related transcriptomic characterization is involved in immune infiltration and correlated with prognosis and immunotherapy response of bladder cancer
por: Xu, Ting, et al.
Publicado: (2022) -
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma
por: D’Andrea, David, et al.
Publicado: (2020) -
Neoadjuvant Chemotherapy in Invasive Bladder Cancer
por: Oliver, R.T.D.
Publicado: (1991) -
Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer
por: Cai, Hongzhou, et al.
Publicado: (2019) -
Mucinous adenocarcinoma of the urinary bladder
por: Baffigo, Giulio, et al.
Publicado: (2012)